Discovery and Evaluation of N-Cyclopropyl-2, 4-Difluoro-5-((2-(Pyridin-2-Ylamino)thiazol-5-Ylmethyl)amino)benzamide (BMS-605541), a Selective and Orally Efficacious Inhibitor of Vascular Endothelial Growth Factor Receptor-2

doi 10.1021/jm060347y.s001